Evidence map›Paper›PMID 42637770›Full record

ArticleNature communications2026

A dual-receptor checkpoint primes enterovirus D68 for respiratory cell entry.

Shengjian Liang, Haoran Guo, Zhili Xu, Zan Liu, Wanying Yang, Xiaoke Liu, Zhenyu Wei, Jichao Hou, Wei Huang, Wei Wang and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Shengjian Liang *Pathogen and Anti-Infection Technology Innovation Center, Yanzhao Advanced Biotechnology and Medicine Laboratory, Institute of Tsinghua University, Hebei, China.ORCID http://orcid.org/0009-0001-7305-4064
Haoran Guo *Institute of Virology and AIDS Research, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, China.
Zhili Xu *Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Zan Liu *National Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing, China.ORCID http://orcid.org/0009-0005-7809-2392
Wanying YangInstitute of Virology and AIDS Research, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, China.
Xiaoke LiuMOE Key Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, China.
Zhenyu WeiMOE Key Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, China.
Jichao HouMOE Key Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, China.
Wei HuangNational Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing, China.
Wei WangState Key Laboratory of Crop Stress Adaptation and Improvement, The Zhongzhou Laboratory for Integrative Biology, School of Life Sciences, Henan University, Jinming Avenue 1, Kaifeng, China.ORCID http://orcid.org/0000-0002-4002-2648
Jiachen LiSchool of Life Sciences, State Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.
Wendong MaMOE Key Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, China.
Zhikang DengMOE Key Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, China.
Haocong QianSchool of Life Sciences, Fudan University, 2005 Songhu Road, Shanghai, China.
Yaxin WangSchool of Life Sciences, State Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China. wangyaxin@tju.edu.cn.ORCID http://orcid.org/0000-0002-3507-3969
Jialin LiuNational Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing, China. jialinliu_bprc@163.com.ORCID http://orcid.org/0000-0002-9450-0772
Zihe RaoMOE Key Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, China. raozh@tsinghua.edu.cn.ORCID http://orcid.org/0000-0001-9866-2384
Wei WeiInstitute of Virology and AIDS Research, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, China. wwei6@jlu.edu.cn.ORCID http://orcid.org/0000-0003-4456-840X
Zhiyong LouPathogen and Anti-Infection Technology Innovation Center, Yanzhao Advanced Biotechnology and Medicine Laboratory, Institute of Tsinghua University, Hebei, China. louzy@mail.tsinghua.edu.cn.ORCID http://orcid.org/0000-0003-2728-881X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MFSD6 is a newly identified receptor that mediates the invasion of respiratory cells by enterovirus D68 (EV-D68), a non-polio enterovirus that causes severe respiratory disease and poliomyelitis-like illness in children. Here, we report near-atomic-resolution cryo-electron microscopy (cryo-EM) structures of historical and contemporary AFM-associated EV-D68 strains, together with their complexes bound to the third extracellular loop of MFSD6 (MFSD6-L3). These structures uncover a previously unrecognized "binary gating switch" mechanism of virus-receptor engagement that differs from the reported model. In this mechanism, the N200-V208 segment of MFSD6, carrying a glycosylated Asn207, inserts into one capsomer, whereas the sialyl-Gal-terminated glycan of MFSD6 engages an adjacent capsomer. Neu5Ac binding induces conformational rearrangements that expel the pocket factor, destabilize the virion, and prime infection. Functional analyses further define the contributions of the receptor-contacting residues and glycans to viral attachment and entry. Together, our findings refine the molecular basis of EV-D68 recognition of MFSD6 and reveal a glycan-mediated dual-lock mechanism that may enhance receptor specificity, prevent premature uncoating, and ensure productive infection only upon engagement of the correct host receptor. These results provide broader insight into enterovirus tropism and establish a framework for structure-guided antiviral design.

Indexed as

Enterovirus D, HumanEnterovirus InfectionsReceptors, VirusVirus InternalizationAnimalsCryoelectron MicroscopyGlycosylationHumansVirus AttachmentReceptors, Virus

Identifiers

PMID42637770
PMCPMC13503871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.